Bambusa Therapeutics
Clinical trials sponsored by Bambusa Therapeutics, explained in plain language.
-
New COPD drug candidate enters first human safety trials
Symptom relief Recruiting nowThis early-stage study tests a new drug, BBT002, in healthy volunteers and people with COPD to see if it is safe and tolerable. Researchers will also look at how the drug moves through the body and whether it shows any signs of helping with COPD symptoms. The study involves 68 pa…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 01:29 UTC
-
New eczema drug enters first human tests
Symptom relief Recruiting nowThis early-stage study tests a new medicine called BBT001 in healthy people and adults with moderate-to-severe eczema (atopic dermatitis). The main goal is to check safety and how the body handles the drug. About 63 participants will receive either the drug or a placebo. This is …
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 01:16 UTC
-
New eczema drug enters first human tests
Symptom relief Recruiting nowThis early-stage study tests a new medicine called BBT001 in healthy people and adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body handles it. About 198 participants will receive either BBT001 or a placebo, an…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC